IGF1R and breast carcinoma: Our findings using the MCF7/IGF-1R breast cancer cell line model provide evidence that elevated IGF-1R signaling determines the sensitivity of breast cancer cells to antiestrogens and further define the role of the IGF-1/IGF-1R axis in the pleiotropic mechanisms of breast cancer antiestrogen resistance.